Anika Therapeutics, Inc. (ANIK)
15.12
+0.17
(+1.14%)
USD |
NASDAQ |
May 06, 16:00
15.50
+0.38
(+2.51%)
Pre-Market: 08:26
Anika Therapeutics Free Cash Flow : 1.039M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| TELA Bio, Inc. | -28.67M |
| BioCryst Pharmaceuticals, Inc. | 327.41M |
| Masimo Corp. | 206.10M |
| Lantheus Holdings, Inc. | 348.64M |
| Evolus, Inc. | -44.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.846M |
| Cash from Investing (Quarterly) | -1.239M |
| Cash from Financing (Quarterly) | -10.35M |
| Free Cash Flow Per Share (Quarterly) | -0.4639 |
| Free Cash Flow to Equity (Quarterly) | -5.765M |
| Free Cash Flow to Firm (Quarterly) | -6.277M |
| Free Cash Flow Yield | 0.48% |